Fusion isoform multiplicity and impact on treatment outcomes in ALK-rearranged non-small cell lung cancer with next-generation tyrosine kinase inhibitors.
- DOI
- 10.1016/j.lungcan.2026.109594
- Published
- 2026-08-26
- Container
- Lung Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2026.109594,
title = {Fusion isoform multiplicity and impact on treatment outcomes in ALK-rearranged non-small cell lung cancer with next-generation tyrosine kinase inhibitors.},
author = {Humbert D and Buisson A and Basset M and Toffart AC and Odier L and Hominal S and Herreman C and Chabaud S and Pérol M and Mc Leer A and Swalduz A.},
year = {2026},
journal = {Lung Cancer},
doi = {10.1016/j.lungcan.2026.109594},
url = {https://doi.org/10.1016/j.lungcan.2026.109594}
}RIS
TY - JOUR TI - Fusion isoform multiplicity and impact on treatment outcomes in ALK-rearranged non-small cell lung cancer with next-generation tyrosine kinase inhibitors. AU - Humbert D AU - Buisson A AU - Basset M AU - Toffart AC AU - Odier L AU - Hominal S AU - Herreman C AU - Chabaud S AU - Pérol M AU - Mc Leer A AU - Swalduz A. PY - 2026 JO - Lung Cancer DO - 10.1016/j.lungcan.2026.109594 UR - https://doi.org/10.1016/j.lungcan.2026.109594 ER -
APA
D, H., A, B., M, B., AC, T., L, O., S, H., C, H., S, C., M, P., A, M. L., & A., S. (2026). Fusion isoform multiplicity and impact on treatment outcomes in ALK-rearranged non-small cell lung cancer with next-generation tyrosine kinase inhibitors.. Lung Cancer. https://doi.org/10.1016/j.lungcan.2026.109594
Source records
- europe-pmc · retrieved 2026-09-25T13:57:14.100Z